Moderna announced Friday it is suing Pfizer and its German partner BioNTech, alleging the two companies copied Moderna’s technology in its development of their COVID-19 vaccine Comirnaty. Modern said in a news release that Pfizer and BioNTech infringed on patents filed between 2010 and 2016 covering its mRNA technology, which Moderna used to develop its own COVID-19 vaccine, Spikevax. “We…
The patent infringement lawsuits were filed in the U.S. District Court for the District of Massachusetts and the Regional Court of Düsseldorf in Germany, according to a news releaseModerna announced Friday it is suing Pfizer and its German partner BioNTech, alleging the two companies copied Moderna's technology in its development of their COVID-19 vaccine Comirnaty.
Modern said in a news release that Pfizer and BioNTech infringed on patents filed between 2010 and 2016 covering its mRNA technology, which Moderna used to develop its own COVID-19 vaccine, Spikevax. "We are filing these lawsuits to protect the innovative mRNA technology platform that we pioneered, invested billions of dollars in creating, and patented during the decade preceding the COVID-19 pandemic," said Moderna CEO Stéphane Bancel."This foundational platform, which we began building in 2010, along with our patented work on coronaviruses in 2015 and 2016, enabled us to produce a safe and highly effective COVID-19 vaccine in record time after the pandemic struck.
The patent infringement lawsuits were filed in the U.S. District Court for the District of Massachusetts and the Regional Court of Düsseldorf in Germany, according to a news release.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Moderna suing Pfizer over vaccine technologyModerna said it’s suing Pfizer and BioNTech over alleged patent infringements, the company announced Friday.
Weiterlesen »
Pfizer COVID shots appear 73% effective in children under 5Only about 6% of youngsters ages 6 months through 4 years had gotten at least one dose of a COVID-19 vaccine.
Weiterlesen »
Study: Pfizer COVID pill showed no benefit in younger adultsPfizer's COVID-19 pill appears to provide little or no benefit for younger adults, while still reducing the risk of hospitalization and death for high-risk seniors, according to a large study published Wednesday.
Weiterlesen »
Study: Pfizer COVID pill showed no benefit in younger adultsPfizer’s COVID-19 pill appears to provide little or no benefit for younger adults, while still reducing the risk of hospitalization and death for high-risk seniors, according to a large study published Wednesday.
Weiterlesen »
Pfizer COVID shots appear 73% effective in children under 5Only about 6% of youngsters ages 6 months through 4 years had gotten at least one dose of a COVID-19 vaccine.
Weiterlesen »